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Blood transfusion in liver transplantation 
P. BUTLER, L. ISRAEL, J. NUSBACHER, D. E. JENKINS, JR., AND T. E. STARZL 
Liver transplantation is a relatively new procedure in which unusually large quantities of 
blood are used. Blood use in 68 adult and 49 pediatric liver transplants was reviewed. The 
median (range) intraoperative red cell use for adults and children was 28.5 (3-251) and 11 
(2-55), respectively. Blood use closely correlated with the patient's primary diagnosis. Adult 
patients with primary biliary cirrhosis and carcinoma used about one-half as much blood as 
those with a diagnosis of sclerosing cholangitis, hepatitis, or cirrhosis. Patients in the 
former diagnostic groups also had better survival rates. Total red cell use for the patient's 
entire hospitalization was about twice that used during surgery. Fresh-frozen plasma use 
paralleled red cell transfusions, but platelet use was modest. These data can serve as a 
baseline in helping other hospital transfusion services prepare for the advent of liver 
transplantation in their institutions. TRANSFUSION 1985;25:120-123. 
UNTIL RECENTLY, liver transplantation was performed 
infrequently and in only a few hospitals in this country. 
Among the factors contributing to the paucity of liver 
transplants have been the lack of available donor 
organs, the difficulty of the surgical procedure, the 
inability to store donor livers after harvesting, the 
inability to perform histocompatibility testing prior to 
transplantation within the necessary time constraints, 
and the relatively high organ rejection rates. However, 
with improved surgical technics, increased public 
awareness of the need for organs, and improved 
immunosuppression, liver transplantation is now 
being introduced in more hospitals. 
Liver transplantation also is associated with the use 
of large volumes of blood, considerably more than 
with most other surgical procedures. This communica-
tion reviews the blood transfusion needs in a large 
number of adult and pediatric patients undergoing 
liver transplantation in our institution over a 2-year 
period. 
Materials and Methods 
Between February 1981 and April 1983, 68 liver trans-
plantations were performed on adults at Presbyterian-
University Hospital and 49 were performed on children at 
Children's Hospital of Pittsburgh. All transplantations were 
performed with cyclosporine immunosuppression. The 
quantity of red cells (RBCs), fresh-frozen plasma (FFP), and 
platelets transfused was ascertained. Intraoperative and 
peri operative transfusions were recorded separately. Trans-
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fusion needs were determined by the transplant surgical team 
or other physicians caring for the patient. 
All RBC transfusions were in the form of red cells 
("packed cells"). No special attention was given to the age of 
units distributed for transfusion. ABO-matched units were 
given unless inventory needs mandated the use of ABO-
compatible, but not specific, units. Rh-negative recipients 
were given Rh-negative units early during surgery, but if 
large amounts of blood were needed, Rh-positive units were 
given routinely. FFP and platelet transfusions were given on 
the basis of clinical need as ascertained by the transplant 
team. 
In 61 of the 68 adult transplant patients, the diagnosis fit 
into one of the following four categories: 1) primary biliary 
cirrhosis, 2) carcinoma, 3) sclerosing cholangitis, and 4) 
hepatitis or cirrhosis. Among the 49 pediatric transplant 
patients, 37 could be categorized into one of the following 
four diagnostic categories: 1) biliary atresia, 2) alpha-I-
antitrypsin deficiency, 3) hepatitis or cirrhosis, and 4) 
carcinoma. 
Of the 68 adult transplant procedures, 15 were retrans-
plantations-a second liver transplant occurring after failure 
of the initial graft. Among the pediatric patients, there were 
19 second transplantations in the initial 49 procedures 
analyzed. Survival was defined as discharge from the 
hospital. 
Results 
Adult procedures 
A frequency distribution of intraoperative RBC use is 
illustrated in Fig. l. Also shown is the mortality (as defined 
above) as a function of the number of units transfused. In 
more than one-half of all procedures (38 of 68), less than 30 
units of blood were transfused. Figure I also illustrates the 
strong correlation between units transfused and patient 
outcome. The survival rate was 60 percent when less than 30 
units were transfused, but only 33 percent when more than 30 
units were given. Only 5 of 15 patients survived after 
retransplantation procedures. 
The use of FFP paralleled red cell use in every aspe~t (data 
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FIG. I. Intraoperative RBC use for 68 adult liver transplantations 
procedures. 
not shown). There was a virtual one-to-one relationship 
between FFP nd RBC infusions. The intraoperative use of 
platelets is illustrated in Figure 2. In 43 of 68 procedures 
(63%), less than 20 units of platelets were given. In 14 
procedures (20%), no platelets were used. 
Intraoperative blood use correlated strongly with the 
patient's primary diagnosis. As shown in Table 1, patients 
with a diagnosis of primary biliary cirrhosis (PBC) or 
carcinoma used less than one-half the quantity of RBCs 
required for patients with sclerosing cholangitis, hepatitis, or 
cirrhosis. Only three of 16 patients with PBC and two of nine 
patients with carcinoma used more than 30 units of RBCs. 
Survival rates in these groups of patients were substantially 
better than those in patients with other diagnoses. 
Pediatric procedures 
A frequency. distribution of intraoperative RBC use in 
children is illustrated in Figure 3. The data are similar to 
those observed in adults (Fig. 1), although the overall 
quantity of blood transfused was considerably less. In 32 of 
49 (65%) procedures, less than 15 units of RBCs were given. 
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FIG.2. Intraoperative platelet use for68 adult liver transplantation 
procedures (See Fig. I for legend). 
Table 1. RBC use In adult liver transplantation procedures 
correia red with patient diagnosis and survival 
Number Intraoperative 
of Median Percent 
Diagnosis Patients (Range) Survival 
Primary biliary 
69 cirrhosis 16 15 (3-123) 
Carcinoma 9 17 (6-65) 67 
Sclerosing cholangitis 8 36 (10-'143) 50 
Hepatitis or cirrhosis 28 3917-251) 46 
However. overall survival correlated less well with blood use 
in children. There was a 65 percent survival rate when less 
than J 5 units of R BCs were transfused and a 58 percent 
survival rate when more than 15 units of RBCs were 
transfused. Among pediatric patients who underwent a 
second transplantation procedure, the survival rate was 47 
percent (9 of ) 9). 
As in adult patients, children with a diagnosis of hepatitis 
or cirrhosis required considerably more RBC transfusions--
nearly twice as many-as those with other conditions (Table 
2). The survival rate in children also correlated with blood 
use when the data were grouped by diagnoses. 
Total blood component use 
Table 3 summarizes the total blood component use for 
both adults and children during the entire hospitalization for 
liver transplantation. The total number of units of RBCs, 
FFP, and platelets before and after surgery was approxi-
mately equivalent to that given intraoperatively. Most 
perioperative transfusion events, however, were not massive, 
but consisted of a few units given during the long pre- and 
postoperative hospitalizations common in these patients. 
Discussion 
Liver transplantation makes unusual demands on 
the blood bank. The total use of red cell products in 
this group of patients (both intra- and perioperative) 
accounted for about 15 percent of all transfusion needs 
in our institution and about 4.7 percent of the 130,000 
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FIG. 3. Intraoperative RBC use for 49 pediatric liver transplanta-
tion procedures (See Fig. I for legend). 
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Table 2. RBC use in pediatric liver transplantation 
procedures correlated with patient diagnosis and survival 
Number Intraoperative 
of Median Percent 
Diagnosis Patients (Range) Survival 
Biliary atresia 20 10 (3-55) 65 
Alpha-1-antitrypsin 
deficiency 8 8 (2-21) 75 
Hepatitis or cirrhosis 6 19 (5-23) 50 
Carcinoma 3 10 (5-15) 100 
units of blood distributed annually to all hospitals 
served by the Central Blood Bank of Pittsburgh. More 
than one-half of these transfusions occurred intra-
operatively, a fact that clearly indicates the need for 
logistic planning by the blood bank in support of these 
procedures. 
Liver transplants occur with little notice. The 
maximal time between donor organ harvest and 
transplantation is less than twelve hours, often 
considerably less. Because of their technical difficulty, 
these procedures take from 6 to 24 hours to perform 
and are often done at night or on weekends. All these 
factors tend to stress the transfusion service's capa-
bility to support these patients. 
In our experience, a key to successful transfusion 
support in liver transplantation is good communica-
tion between the transplant team and the transfusion 
service. The transfusion service must be notified 
immediately when an organ becomes available and the 
recipient is selected. This permits accumulation of red 
cell and other transfusion prod uets of the proper type 
and in the necessary amount. Good communication is 
also important during surgery. The occurrence of 
unexpected bleeding or technical problems should be 
relayed immediately to the transfusion service so that 
adequate quantities of blood can be prepared in 
advance. 
The magnitude of bleeding during liver transplanta-
tion appears to result from two factors: the poor 
hemostatic capabilities of many of these patients and 
the technical difficulty of the surgical procedure. The 
former problem is the subject of another communica-
tion. I The latter, as indicated in Tables I and 2, is a 
major factor in determining not only blood use but 
also patient survival (Figs. 1 and 3). Patients with 
sclerosing cholangitis and hepatitis or cirrhosis usually 
have severe portal hypertension which results in the 
proliferation and engorgement of collateral blood 
vessels which tend to bleed profusely during surgery. 
Furthermore, these patients often have had previous 
operations which tends to make surgical dissection and 
vascular anastamoses much more difficult. In these 
cases, much of the intraoperative bleeding occurs early 
in the procedure, dunng the removal of the recipient's 
diseased liver and during the anhepatic period. In 
contrast, patients with primary biliary cirrhosis or 
carcinoma often have "cleaner" surgical fields and the 
dissection proceeds with greater ease. These patients 
use less blood and have a better prognosis. 
These observations can form the basis for readying 
the transfusion service for liver transplantation pro-
cedures. Adult patients with primary biliary cirrhosis 
or carcinoma need have only 20 units available with 20 
held in reserve. Other patients will need about twice 
this number. A similar strategy can be developed for 
pediatric recipients. In our view, standard compati-
bility tests need be done for only the first 10 to 20 units 
transfused. Rechecking the donor's ABO type (e.g., 
immediate spin) is all that is required thereafter. 
When the transplant recipient has a clinically 
significant alloantib6dy, additional planning is re-
quired. A satisfactory approach has been to use blood 
negative for the antibody specificity for the first 10 to 
20 units. If substantial bleeding continues, any 
available ABO-compatible blood can be used until 
close to the end of the procedure. Administration of 
antigen-negative blood is then resumed for the 
estimated final 10 to 20 units. This approach has been 
used in a number of our transplant patients-in a 
patient with anti-c and anti-E or anti-D for example-
Table 3 Total blood components used dunng surgery and perioperatively in 68 adult and 
Totai during operation 
Range per transplant 
Total during hospital stay 
Mean oer ;JalienT per hospital stay 
Range per oatien! 
• RBC-Red cell concentrate 
T r-FP -Fr"sr,-irozen plasma. 
± PLT -Platelet donor units. 
49 pediatTic liver transplant procedures 
Adult procedures 
RBC' FFPt PLT:j: 
2968 2808 1365 
3-251 2-206 0-107 
4808 5131 3924 
71 75 58 
6-254 4-235 0-404 
Pediatric procedures 
RBC FFP PLT 
688 774 348 
2-59 2-67 0-35 
1357 1838 902 
28 38 19 
4-143 4-190 0-108 
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with no ill effects or delayed hemolytic transfusion 
reactions. However, it also demands excellent com-
munication with the surgical team during the 
operation. 
The large amount of FFP used in our patients 
reflects, in pan, the poor hemostatic capabilities of 
many of the liver transplant recipients. Bontempo et 
al.I showed a correlation between the number of 
coagulation abnormalities prior to liver transplanta-
tion and the quantity of red cells transfused during the 
procedure. In addition, little whole blood is available 
in our region because the overall demand for 
components is so great. In our opinion, the use of 
whole blood, or a combination of whole blood and 
packed cells supplemented by either occasional FFP, 
single donor plasma, or cryoprecipitate would be an 
equally effective approach. 
The use of intraoperative autologous transfusion in 
liver transplantation is desirable because it is possible 
that the blood bank's inventory could be depleted by 
this procedure. We have used this technic (Cell Saver, 
Haemonetics Corp, Braintree, MA) in a few patients. 
We found that the equipment could not handle 
effectively the large volume of blood presented to it; 
therefore, the surgeon had to switch back and forth 
between the standard suction apparatus and suction 
destined for reinfusion. This relatively minor problem 
could be solved by making minor alterations in the 
suction equipment, using more than one autologous 
infusion set, or by the development of faster autologous 
infusion equipment. 
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